Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia

Metabolic Brain Disease

Volumn 20, Issue 4, 2005, Pages 265-274

  Monfort, Pilar ^a   Muñoz, María Dolores ^b   Felipo, Vicente ^a  

^a Laboratorio de Neurobiologia de Prince Felipe Research Centre   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

cGMP; Hyperammonemia; Long term potentiation

Indexed keywords

8 BROMO CYCLIC AMP; AMMONIA; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHODIESTERASE;

BRAIN SLICE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEGRADATION KINETICS; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME MECHANISM; EXPERIMENTAL RAT; HIPPOCAMPUS; HYPERAMMONEMIA; LIVER DISEASE; LONG TERM POTENTIATION; MOLECULAR BIOLOGY; NEUROPATHOLOGY; NONHUMAN; PHOSPHATE METABOLISM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TETANUS;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GUANYLATE CYCLASE; HIPPOCAMPUS; HUMANS; HYPERAMMONEMIA; LONG-TERM POTENTIATION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 29744453130     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-005-7905-5     Document Type: Conference Paper

References (32)

1. Akers, R.F., Lovinger, D.M., Colley, P.A., Linden, D.J., and Routtenberg, A. (1986). Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 231:587-589.
2. Blitzer, R.D., Wong, T., Nouranifar, R., Iyengar, R., and Landau, E.M. (1995). Postsynapyic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron 15:1403-1414.
3. Böhme, G.A., Bon, C., Stutzmann, J.M., Doble, Á., and Blanchard, J.C. (1991). Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol. 199:379-381.
4. Boulton, C.L., Southam, E., and Garthwaite, J. (1995). Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69:699-703.
5. Chetkovich, D.M., Klann, E., and Sweatt, J.D. (1993). Nitric oxide synthase-independent long-term potentiation in area CA1 of hippocampus. NeuroReport 4:919-922.
6. Corbin, J.D., Turko, I.V., Beasley, A., and Francis, S.H. (2000). Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem. 267:2760-2767.
7. Doyle, C., Hölscher, C., Rowan, M.J., and Anwyl, R. (1996). The selective neuronal NO synthase inhibitor 7-nitroindazole blocks both long-term potentiation and depotentiation of field EPSPs in rat hippocampal CA1 in vivo. J. Neurosci. 16:418-424.
8. Felipo, V., and Butterworth, R.F. (2002). Neurobiology of ammonia. Prog. Neurobiol. 67:259-279.
9. Hawkins, R.D. (1996). NO honey, I don't remember. Neuron 16:465-467.
10. Hermenegildo, C., Montoliu, C., Llansola, M., Muñoz, M.D., Gaztelu, J.M., Miñana, M.D., and Felipo, V. (1998). Chronic hyperammonemia impairs the glutamate-nitricoxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10:3201-3209.
11. Hu, G.Y., Hvalby, O., Walaas, S.I., Albert, K.A., Skjeflo, P., Andersen, P., and Greengard, P. (1987). Protein kinase C injection into hippocampal pyramidal cells elicits features of long term potentiation. Nature 328:426-429.
12. Lombardi, G., Mannaioni, P., Leonardi, P., Cherici, G., Carlà, V., and Moroni, F. (1994). Ammonium acetate inhibits ionotropic receptors and differentially affects metabotropic receptors for glutamate. J. Neural Transm. Gen. Sect. 97:187-196.
13. Louis, J.C., Revel, M.O., and Zwiller, J. (1993). Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim. Biophys. Acta 1177: 299-306.
14. Lovinger, D.M., Wong, K.L., Murakami, K., and Routtenberg, A. (1987). Protein kinase C inhibitors eliminate hippocampal long-term potentiation. Brain Res. 436:177-183.
15. Lu, Y., Kandel, E.R., and Hawkins, R.D. (1999). Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J. Neurosci. 19: 10250-10261.
16. Marcaida, G., Miñana, M.D., Burgal, M., Grisolia, S., and Felipo, V.(1995). Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures Eur. J. Neurosci. 7:2389-2396.
17. Michalak, A., Knecht, K., and Butterworth, R.F. (1997). Hepatic encephalopathy in acute liver failure: role of the glutamate system. Adv. Exp. Med. Biol. 420:35-44.
18. Miñana, M.D., Llansola, M., Hermenegildo, C., Cucarella, C., Montoliu, C., Grisolía, S., and Felipo, V. (1997). Glutamate and muscarinic receptors in the molecular mechanism of acute ammonia toxicity and of its prevention. Adv. Exp. Med. Biol. 420:45-56.
19. Monfort, P., Muñoz, D., and Felipo, V. (2004). Hyperammonemia impairs long-term potentiation in hippocampus by alterating the modulation of cGMP-degrading phosphodiesterase by protein kinase G. Neurobiol. Dis. 15:1-10.
20. Monfort, P., Muñoz, D., Kosenko, E., and Felipo, V. (2002). Long- Term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J. Neurosci. 22:10116-10122.
21. Moroni, F., Lombardi, G., Moneti, G., and Cortesini, C. (1983). The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J. Neurochem. 40:850-854.
22. Muñoz, D., Monfort, P., and Felipo, V. (2000). Hyperammonemia impairs NMDA receptor-dependent long-term-potentiation in the CA1 of rat hippocampus in vitro. Neurochem. Res. 25:437-441.
23. O'Dell, T.J., Hawkins, R.D., Kandel, E.R., and Arancio, O. (1991). Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. 88:11285-11289.
24. Schuman, E.M., and Madison, D.V. (1991). A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254:503-1506.
25. Schuman, E.M., Meffert, M.K., Schulman, H., and Madison, D.V. (1994). An ADP-ribosyl transferase as a potential target for nitric oxide action in hippocampal long-term potentiation. Proc. Natl. Acad. Sci. 91:11958-11962.
26. Selig, D.K., Segal, M.R., Liao, D., Malenka, R., Malinow, R., Nicoll, R.A., and Lisman, J.E. (1996). Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus. Learn. Memory 3:42-48.
27. Thomas, M.K., Francis, S.H., and Corbin, J.D. (1990). Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. J. Biol. Chem. 265:14971-14978.
28. Wu, J., Wang, Y., Rowan, M.J., and Anwy, L.R. (1998). Evidence for involvement of the cGMP-protein kinase G signaling system in the induction of long term depression, but not long-term potentiation, in the dentate gyrus in vitro. J. Neurosci. 18:3589-3596.
29. Wyatt, T.A., Naftilan, A.J., Francis, S.H., and Corbin, J.D. (1998). ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am. J. Physiol. 274:448-455.
30. Zhuo, M., Hu, Y., Schultz, C., Kandel, E.R., and Hawkins, R.D. (1994). Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368:635-639.
31. Zwiller, J., Revel, M.O., and Basset, P. (1981). Evidence for phosphorylation of rat brain guanylate cyclase by cyclic-AMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 101:1381-1387.
32. Zwiller, J., Revel, M.O., and Malviya, A.N. (1985). Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J. Biol. Chem. 260:1350-1353.